Ms Julie Fereday
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology
128 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
DOI: 10.1038/s41467-026-71134-32026
Journal article
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)
DOI: 10.1016/j.ijgc.2025.1030762025
Other
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
DOI: 10.1158/1078-0432.307085052025
Other
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
DOI: 10.1158/1078-0432.307085022025
Journal article
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
DOI: 10.1016/j.ygyno.2025.05.0132024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature14410
RECENT SCHOLARLY WORKS
2025
Journal article
Co-Amplification Of CCNE1 And AKT2 As Prognostic Biomarker And Therapeutic Target In Tubo-Ovarian High-Grade Serous Carcinoma
DOI: 10.1016/j.ijgc.2025.1016842024
Journal article
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
DOI: 10.1172/JCI1795012024
Journal article
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
DOI: 10.1038/s41698-024-00519-82024
Journal article
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
DOI: 10.1038/s41525-024-00395-y2024
Journal article
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
DOI: 10.1038/s41467-024-50137-y